Close Menu

NEW YORK (GenomeWeb) – FDA Commissioner and personalized medicine champion Scott Gottlieb announced he will resign as the head of the agency in a month. 

In a letter to HHS Secretary Alex Azar, Gottlieb highlighted his efforts to modernize the development process for novel medical technologies, gene therapies, and targeted treatments as among his accomplishments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.